Mar 11, 2026 8:00 am EDT Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant
Feb 23, 2026 8:00 am EST Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space
Feb 19, 2026 8:00 am EST Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial
Feb 17, 2026 8:00 am EST Envoy Medical Nears Completion of Enrollment in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant
Feb 12, 2026 4:05 pm EST Envoy Medical Announces Closing of Up to $78.0 Million Upsized Public Offering
Feb 11, 2026 9:25 am EST Envoy Medical Announces Pricing of Up to $78.0 Million Upsized Public Offering
Dec 18, 2025 8:00 am EST Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant
Dec 16, 2025 8:00 am EST Envoy Medical Secures New Australian Patent for Cochlear Implant Innovation Aimed at Enhancing Input Signal-to-Noise Ratio
Dec 10, 2025 8:00 am EST Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear Implant
